Allarity Therapeutics, Inc.
ALLR
$1.52
-$0.16-9.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 54.74% | 75.79% | -42.42% | 28.91% | -332.81% |
| Total Depreciation and Amortization | 700.00% | -980.00% | 1,100.00% | 450.00% | -88.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,436.79% | -97.37% | 111.83% | 141.35% | 96.92% |
| Change in Net Operating Assets | -129.76% | 77.26% | 4.68% | -105.16% | 25.13% |
| Cash from Operations | -1.15% | 37.35% | 24.96% | -91.99% | -91.75% |
| Capital Expenditure | 97.32% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 97.32% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -94.24% | -54.86% | -100.00% | 27,757.50% | 709.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.67% | -52.55% | -109.75% | 707.46% | 711.30% |
| Foreign Exchange rate Adjustments | 278.17% | 199.49% | -2,110.71% | -273.33% | 508.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -306.36% | -17.66% | -152.34% | 5,496.58% | 186.78% |